Exelixis faces proxy battle with investor Farallon Capital: report
sanjeri/E+ via Getty Images Update 21:00: Add comment Exelixis. exélixis (NASDAQ:EXEL) will face a proxy battle with hedge fund Farallon ...
Tag: Exelixis
Exelixis has mixed ruling in Cabometyx patent trial, wins in 2026, loses in 2030
sanjeri/E+ via Getty Images Update 20:15: Add Exelixis's comment. exélixis (NASDAQ:EXEL) had a mixed ruling in its Cabometyx vs. MSN ...
Recommended.
